US 9586975
Macrocyclic salt-inducible kinase inhibitors
granted A61KA61K31/5025A61K31/519
Quick answer
US patent 9586975 (Macrocyclic salt-inducible kinase inhibitors) held by Oncodesign SA expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oncodesign SA
- Grant date
- Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/5025, A61K31/519, A61P, A61P17/00